Metraipolis › archive › dc_1a338c7cd263

Efficacy and safety of topical human keratinocyte growth factor-2 for dry eye disease: evidence from in vivo studies — Europe PMC PMID:41958939

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41958939
DOI
10.3389/fphar.2026.1800966
License (as archived)
solo-consultazione
Archived
2026-10-08T04:04:08.641Z
SHA-256 of the archived text
be95b6758b1ee1a91a998bad82c8bad7d3e242b833f41b6649bb4156f57c279f
Stable URL of this page
https://metraipolis.com/documento/dc_1a338c7cd263

How to cite

Efficacy and safety of topical human keratinocyte growth factor-2 for dry eye disease: evidence from in vivo studies — Europe PMC PMID:41958939 — Europe PMC (en), https://europepmc.org/article/MED/41958939 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1a338c7cd263 (Metraipolis archive dc_1a338c7cd263, sha256 be95b6758b1ee1a91a998bad82c8bad7d3e242b833f41b6649bb4156f57c279f)
BibTeX
@misc{dc1a338c7cd263,
  title = {Efficacy and safety of topical human keratinocyte growth factor-2 for dry eye disease: evidence from in vivo studies — Europe PMC PMID:41958939},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41958939},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1a338c7cd263; sha256 be95b6758b1ee1a91a998bad82c8bad7d3e242b833f41b6649bb4156f57c279f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41958939. Agents can read the archived copy with the MCP tool read_document.